Top

Published in:

01-06-2017 | Commentary

PIPAC puts pressure on peritoneal metastases from pancreatic cancer

Author: Jonathan P. Sleeman

Published in: Clinical & Experimental Metastasis | Issue 5/2017

Excerpt

The seeding of metastases into the peritoneal cavity is a feature of a number of gynecological and gastrointestinal cancers, and is termed peritoneal carcinomatosis when metastasis is extensive [1]. The incidence varies according to the cancer type (Table 1). The development of ascites is a further complication associated with peritoneal metastasis. …

van Baal JO, Van de Vijver KK, Nieuwland R, van Noorden CJ, van Driel WJ, Sturk A, Kenter GG, Rikkert LG, Lok CA (2017) The histophysiology and pathophysiology of the peritoneum. Tissue Cell 49:95–105. doi:10.1016/j.tice.2016.11.004 CrossRefPubMed

McMullen JRW, Selleck M, Wall NR, Senthil M (2017) Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy. Oncotarget. doi:10.18632/oncotarget.16480 PubMedPubMedCentral

Aoyagi T, Terracina KP, Raza A, Takabe K (2014) Current treatment options for colon cancer peritoneal carcinomatosis. World J Gastroenterol 20:12493–12500. doi:10.3748/wjg.v20.i35.12493 CrossRefPubMedPubMedCentral

Lambert LA (2015) Looking up: recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin 65:284–298. doi:10.3322/caac.21277 CrossRefPubMed

Newton AD, Bartlett EK, Karakousis GC (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol 7:99–111. doi:10.3978/j.issn.2078-6891.2015.100 PubMedPubMedCentral

Piso P, Arnold D (2011) Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer. Deutsches Arzteblatt Int 108:802–808. doi:10.3238/arztebl.2011.0802

Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hubner M (2017) Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg 104:669–678. doi:10.1002/bjs.10521 CrossRefPubMed

Girshally R, Demtroder C, Albayrak N, Zieren J, Tempfer C, Reymond MA (2016) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 14:253. doi:10.1186/s12957-016-1008-0 CrossRefPubMedPubMedCentral

Blanco A, Giger-Pabst U, Solass W, Zieren J, Reymond MA (2013) Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol 20:2311–2316. doi:10.1245/s10434-012-2840-2 CrossRefPubMedPubMedCentral

10.

Tempfer CB, Winnekendonk G, Solass W, Horvat R, Giger-Pabst U, Zieren J, Rezniczek GA, Reymond MA (2015) Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol 137:223–228. doi:10.1016/j.ygyno.2015.02.009 CrossRefPubMed

11.

Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P, Mortensen MB (2017) Peritoneal carcinomatosis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Clin Exp Metastasis. doi:10.1007/s10585-017-9849-7 PubMed

12.

Kakchekeeva T, Demtroder C, Herath NI, Griffiths D, Torkington J, Solass W, Dutreix M, Reymond MA (2016) In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Ann Surg Oncol 23:592–598. doi:10.1245/s10434-016-5108-4 CrossRefPubMedPubMedCentral

Title: PIPAC puts pressure on peritoneal metastases from pancreatic cancer
Author: Jonathan P. Sleeman
Publication date: 01-06-2017
Publisher: Springer Netherlands
Published in: Clinical & Experimental Metastasis / Issue 5/2017
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-017-9851-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2017

Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?

Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth

The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review

Next generation sequencing of progressive colorectal liver metastases after portal vein embolization

Patterns of metastatic progression after definitive radiation therapy for early-stage and locally advanced non-small cell lung cancer

Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer